Rare diseases
Investigational molecules
Locations
Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors
BulgariaStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
CzechiaStudy on the Effects of Cerebrolysin and Sodium Chloride for Recovery in Patients with Moderate to Severe Traumatic Brain Injury
RomaniaStudy on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions
GermanyStudy on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis
BelgiumStudy on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease
FranceStudy of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia
DenmarkStudy on Continuing or Stopping Imatinib in Patients with Advanced or Metastatic Gastrointestinal Stromal Tumors After 10 Years of Treatment
FranceStudy on the Safety and Effects of ION582 for Patients with Angelman Syndrome
FranceStudy of Combined Imaging with Hyperpolarized [1-13C]Pyruvate and Fludeoxyglucose (18F) for Cancer Detection in Patients with Breast Cancer, Neuroendocrine Tumors, Lymphomas, or Sarcomas
DenmarkStudy on Treatment Strategies for Children and Adolescents with Juvenile Idiopathic Arthritis Using Methotrexate and Drug Combination
NorwayStudy on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
